A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT00362349 ·Status: COMPLETED ·Phase: PHASE3

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00828750 ·Status: COMPLETED ·Phase: PHASE3

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

NCT00220727 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

NCT00244257 ·Status: TERMINATED ·Phase: PHASE1

Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

NCT01727999 ·Status: COMPLETED

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

NCT00102323 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

NCT00168038 ·Status: COMPLETED ·Phase: PHASE3

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

NCT00102336 ·Status: COMPLETED ·Phase: PHASE3

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

NCT00621894 ·Status: COMPLETED ·Phase: PHASE2

IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients

NCT02854059 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura

NCT00005652 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT01713738 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura

NCT00699140 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

NCT00770562 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

NCT02077192 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

NCT00157079 ·Status: COMPLETED ·Phase: PHASE3

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

NCT00486421 ·Status: COMPLETED ·Phase: EARLY_PHASE1

IGIV Study for Chronic ITP Patients Ages 3-70

NCT00511147 ·Status: COMPLETED ·Phase: PHASE3

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

NCT00713193 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

NCT06544499 ·Status: RECRUITING ·Phase: PHASE3

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

NCT00547066 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

NCT00907751 ·Status: COMPLETED ·Phase: PHASE2

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT05422365 ·Status: COMPLETED ·Phase: PHASE3

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

NCT05468320 ·Status: COMPLETED ·Phase: PHASE3